5Q0C

Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-[5-(4-methoxyphenyl)thiophen-2-yl]sulfonylurea and with fructose-2,6-diphosphate

Changes made to a PDB entry after its initial release are considered to be either “major” or “minor”. The latest minor version of each major version is available as a file download. More information about the PDB versioning is available.

Version Number	Version Date	Version Type/Reason	Version Change	Revised CIF Category
1.0	2019-01-09	Initial release
1.1	2019-01-16		Data collection	diffrn_radiation
1.2	2019-02-06		Data collection, Database references, Structure summary	audit_author, citation_author
1.3	2020-07-29	Remediation / Carbohydrate remediation	Data collection, Derived calculations, Structure summary	chem_comp, entity, pdbx_chem_comp_identifier, pdbx_entity_nonpoly, struct_site, struct_site_gen
1.4	2021-02-10		Structure summary	audit_author, chem_comp
1.5	2024-03-06		Data collection, Database references, Refinement description	chem_comp_atom, chem_comp_bond, database_2, struct_ncs_dom_lim	Download

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.